Orexo Announces Results Confirming The Clinical Profile Of OX17 In Reflux Disease (GERD)
medicalnewstoday.com     Mar 28, 2008            

New clinical data from a phase II study confirms the competitive profile of Orexo's product OX17 in GERD patients, i.e. fast, effective and sustained inhibition of gastric acid production, a prerequisite for effective symptom relief in the patient. The result demonstrates the clinical potential... [read full story]                

Add a comment to the article
Type the code shown

View all news articles about:

- Related Topics

View other selected articles:

                   

Astellas and Boehringer file patent infringement lawsuit against Impax

pharmaceutical-business-review.com     2 hrs ago          

Astellas pharma and Boehringer Ingelheim Pharmaceuticals have jointly filed a patent infringement lawsuit in the US against Impax laboratories regarding its submission of an abbreviated new drug application for a generic...                

comments

Sparta Systems Demonstrates Continued Expansion in Global Life Science Markets

prnewswire.com     13 hrs ago   1 related          

Sparta Systems Demonstrates Continued Expansion in Global Life Science Markets New European customers signify worldwide requirements for quality management and regulatory compliance solutions HOLMDEL, N.J., July 22 /PRNewswire/...                

comments

                   

Biota and GSK Conclude Litigation Through Mediation

redorbit.com     yesterday   26 related          

Posted on: Monday, 21 July 2008, 12:01 CDT Biota Holdings Limited (ASX: BTA) today announced it had concluded its litigation against GlaxoSmithKline (GSK). Biota and GSK have agreed to normalise their relationship to pursue the...                

comments

                   

By 2012, Legitimate Generics Will Account For 20% Of Brazil's Pharmaceuticals And Healthcare Market

medicalnewstoday.com     Jul 19, 2008   1 related          

Research and Markets has announced the addition of the "Brazil Pharmaceuticals and Healthcare Report Q2 2008" report to their offering. The "Brazil Pharmaceuticals and Healthcare Report" provides independent forecasts and...                

comments